Author:
Huang Hongying,Liu Guangchao,Qi Yijun,Du Yaowu,Chen Jugao,Ma Yuanfang
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Wang Y, Mai T, Liu M F, Chen S H. Effect of lipoteichoic acid of Bifidobacterium on survivin and its regulatory genes. Zhonghua Zhong Liu Za Zhi, 2007, 29(5): 325–328(in Chinese)
2. Pavne A G. Exploiting hypoxia in solid tumors to achieve oncolysis. Med Hypotheses, 2007, 68(4): 828–831
3. Fujimori M. Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. Breast Cancer, 2006, 13(1): 27–31
4. Le Leu R K, Brown I L, Hu Y, Bird A R, Jackson M, Esterman A, Young G P. Asynbiotic combination of resistant starch and Bifidobacterium lactis facilitates apoptotic deletion of carcinogen-damaged cells in rat colon. J Nutr, 2005,135(5): 996–1001
5. Zeuthen L H, Christensen H R, Frokiaer H. Lactic acid bacteria inducing a weak interleukin-12 and tumor necrosis factor alpha response in human dendritic cells inhibit strongly stimulating lactic acid bacteria but act synergistically with gramnegative bacteria. Clin Vaccine Immunol, 2006, 13(3): 365–375